EGFR and neoplasm: It shares several similarities with advanced or recurrent HNSCC, including tumor biology (both tumors are locally invasive and cause malignant osteolysis), molecular markers (EGFR, p53) and poor response of advanced stage disease to conventional therapies [36, 37].